Clin Endosc.  2019 May;52(3):205-206. 10.5946/ce.2019.093.

Commentary on “Efficacy of Endoscopic Submucosal Dissection of Esophageal Neoplasms under General Anesthesia”

• Choi SI
• Park JC

• KMID: 2449756
• DOI: http://doi.org/10.5946/ce.2019.093

Abstract

No abstract available.

MeSH Terms

Esophageal Neoplasms*

Reference

1. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013; 381:400–412.

2. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998; 123:432–439.

3. Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002; 94:570–575.

4. Fujita H, Sueyoshi S, Yamana H, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg. 2001; 25:424–431.

5. Park JS, Youn YH, Park JJ, Kim JH, Park H. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal squamous neoplasms. Clin Endosc. 2016; 49:168–175.

6. Li X, Dong H, Zhang Y, Zhang G. CO2 insufflation versus air insufflation for endoscopic submucosal dissection: a meta-analysis of randomized controlled trials. PLoS One. 2017; 12:e0177909.

7. Kim SY, Chung JW, Park DK, Kwon KA, Kim KO, Kim YJ. Efficacy of carbon dioxide insufflation during gastric endoscopic submucosal dissection: a randomized, double-blind, controlled, prospective study. Gastrointest Endosc. 2015; 82:1018–1024.

8. ASGE Technology Committe, Lo SK, Fujii-Lau LL, et al. The use of carbon dioxide in gastrointestinal endoscopy. Gastrointest Endosc. 2016; 83:857–865.

9. Mori H, Kobara H, Muramatsu A, et al. Comparison of postoperative complications after endoscopic submucosal dissection: differences of insufflations and anesthesias. Diagn Ther Endosc. 2011; 2011:709237.

10. Yurtlu DA, Aslan F, Ayvat P, et al. Propofol-based sedation versus general anesthesia for endoscopic submucosal dissection. Medicine (Baltimore). 2016; 95:e3680.

11. Park CH, Shin S, Lee SK, et al. Assessing the stability and safety of procedure during endoscopic submucosal dissection according to sedation methods: a randomized trial. PLoS One. 2015; 10:e0120529.

12. Rong QH, Zhao GL, Xie JP, Wang LX. Feasibility and safety of endoscopic submucosal dissection of esophageal or gastric carcinomas under general anesthesia. Med Princ Pract. 2013; 22:280–284.

13. Yamashita K, Shiwaku H, Ohmiya T, et al. Efficacy and safety of endoscopic submucosal dissection under general anesthesia. World J Gastrointest Endosc. 2016; 8:466–471.

14. Song BG, Min YW, Cha RR, et al. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes. BMC Gastroenterol. 2018; 18:80.

15. Hamada K, Kawano K, Yamauchi A, et al. Efficacy of endoscopic submucosal dissection of esophageal neoplasms under general anesthesia. Clin Endosc. 2019; 52:252–257.